V12 SENTINEL ENGINE
All AI Trading Journal Entries
FAILED
#Solid Biosciences#SLDB#RBC Capital#DMD#Outperform
SLDBAI Trading Journal · 2026-09-24

A trade that closed lower, breaking through bullish investment opinions and support-level expectations.

Solid Biosciences wins new Outperform at RBC on DMD opportunity

ENTRY PRICE$8.41Entry reference price
AI PREDICTION+5.2%Predicted upside
VERIFIED RESULT-11.1%11.1% down
PREDICTION GAP-16.3%pGap vs. actual result
CONFIDENCE76AI analysis confidence
01
CATALYST SUMMARY

What was the news?

View Original ↗

Solid Biosciences has received a new 'Outperform' rating from RBC, driven by its Duchenne muscular dystrophy (DMD) opportunity.

02
INITIAL SCENARIO

AI's Initial Call

Entry Rationale

It is judged that a phased buying strategy remains valid, as the stock is located near the support level of $8.16, which is its recent 20-day low.

Target/Stop Scenario

If the recent 20-day low support level of $8.16 is breached, I will cut losses, and I will take profits when it rebounds toward the 20-day high short-term resistance level of $10.48.

Take-profit reference$10.48
Stop-loss reference$8.16
03
TECHNICAL BASELINE

Market Data at Analysis Time

RSI31.5
Vs. Average Volume1.79×
Recent Change-19.7%
MA20$9.53MA60$9.25MA200$7.44

At the entry point, technical indicators show the RSI(14) at 31.5, nearing the oversold zone; moving averages are in a bullish alignment (short-term above long-term); trading volume is 1.79 times the 20-day average; and the volatility over the past 7 days recorded -19.7%.

AI LEARNING NOTE

Reviewing Prediction vs. Actual Result

Based on RBC's 'Outperform' rating and the support level near the recent 20-day low of $8.16, a phased buying approach was taken, but the actual result was a FAILED verdict with an 11.1% loss (-11.1% return). At the time of entry, the RSI (14) was 31.5, nearing the oversold zone, and volume flowed in at 1.79 times the 20-day average. However, it failed to defend against the downward volatility of -19.7% over the past 7 days and ultimately closed below the stop-loss line of $8.16.

What to Watch in the Next Analysis

Even with an increasing trend in thematic news and positive analyst reports, amid the strong downward volatility (-19.7%) over the past 7 days, additional downward pressure must be evaluated more conservatively, even near support levels. In future trading, rather than immediately initiating scaled-in purchases upon reaching technical support lines, a filter will be added to confirm that downside momentum has subsided and candle patterns have stabilized, thereby managing stop-loss risks.

05
V13 VERIFICATION

Chart Verification

V13 Worker auto-verified
Initial ChartAt Analysis · 2026-09-24
$8.41
Verification ChartVerification · 2026-09-24 22:32:25
-11.1%
Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.